Pages that link to "Q46535610"
Jump to navigation
Jump to search
The following pages link to Koleka Mlisana (Q46535610):
Displaying 50 items.
- Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women (Q24613572) (← links)
- Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women (Q24629582) (← links)
- Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region (Q28534875) (← links)
- Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection (Q30485614) (← links)
- Enrolling adolescents in research on HIV and other sensitive issues: lessons from South Africa (Q33239623) (← links)
- Anaemia in acute HIV-1 subtype C infection (Q33320529) (← links)
- Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage (Q33325923) (← links)
- Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study (Q33328477) (← links)
- Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection (Q33504604) (← links)
- Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. (Q33606936) (← links)
- Health-related quality of life dynamics of HIV-positive South African women up to ART initiation: evidence from the CAPRISA 002 acute infection cohort study (Q33610865) (← links)
- HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection (Q33614208) (← links)
- Impact of antiretroviral therapy on health-related quality of life among South African women in the CAPRISA 002 acute infection study (Q34021927) (← links)
- HIV prevention in high-risk women in South Africa: condom use and the need for change (Q34170153) (← links)
- Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study (Q34240204) (← links)
- Pregnancy incidence and correlates during the HVTN 503 Phambili HIV vaccine trial conducted among South African women (Q34244965) (← links)
- Fluidity of HIV-1-specific T-cell responses during acute and early subtype C HIV-1 infection and associations with early disease progression (Q34295981) (← links)
- Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression (Q34402041) (← links)
- Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection (Q34458011) (← links)
- Challenges of diagnosing acute HIV-1 subtype C infection in African women: performance of a clinical algorithm and the need for point-of-care nucleic-acid based testing (Q34706934) (← links)
- Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial (Q34712820) (← links)
- Rapid disease progression in HIV-1 subtype C-infected South African women (Q34736181) (← links)
- Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop (Q34742533) (← links)
- The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection (Q35076717) (← links)
- Virological and immunological factors associated with HIV-1 differential disease progression in HLA-B 58:01-positive individuals (Q35077768) (← links)
- Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis (Q35109877) (← links)
- Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa (Q35140032) (← links)
- Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier (Q35508247) (← links)
- Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression (Q35600919) (← links)
- Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women (Q35628640) (← links)
- Evolution of epidemiologic methods and concepts in selected textbooks of the 20th century (Q35777079) (← links)
- Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection (Q35857268) (← links)
- Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin (Q36107520) (← links)
- Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants (Q36119504) (← links)
- Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study (Q36158727) (← links)
- Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells (Q36303623) (← links)
- APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load (Q36316091) (← links)
- Temporal association of HLA-B*81:01- and HLA-B*39:10-mediated HIV-1 p24 sequence evolution with disease progression. (Q36363854) (← links)
- Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa (Q36376181) (← links)
- Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness (Q36414578) (← links)
- The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection (Q36483346) (← links)
- Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial (Q36739446) (← links)
- Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point (Q37033201) (← links)
- Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression (Q37039116) (← links)
- Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants (Q37145228) (← links)
- Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection (Q37301445) (← links)
- Broad neutralization of human immunodeficiency virus type 1 mediated by plasma antibodies against the gp41 membrane proximal external region (Q37410792) (← links)
- Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point (Q37473934) (← links)
- Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point (Q37547306) (← links)
- Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa? (Q37617853) (← links)